Recruiting PHASE3 INTERVENTIONAL 2-arm NCT05764044

Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer (AddChemo)

Adjuvant Chemotherapy in Cell-free Human Papillomavirus Deoxyribonucleic Acid (cfHPV-DNA) Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer (CC)

Sponsor: Hospital do Coracao

Conditions Cervical Cancer Cervix Cancer Cervix Neoplasm

Interventions Follow-up cisplatin, gemcitabine

Updated 5 times since 2023 Last updated: Jul 28, 2024 Started: Mar 27, 2024 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cervical Cancer and Cervix Cancer and is currently actively recruiting participants. Hospital do Coracao leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE3
Sep 2024 — Sep 2025 [monthly]

Recruiting PHASE3
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting PHASE3
Apr 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital do Coracao
University of Sao Paulo

Data source: Hospital do Coracao

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bento Gonçalves, Brazil , Boa Vista, Brazil , Brasília, Brazil , Cachoeiro de Itapemirim, Brazil , Campinas, Brazil , Cascavel, Brazil , Caxias do Sul, Brazil , Curitiba, Brazil , Itajaí, Brazil , Jales, Brazil and 10 more locations